(BCRX) Biocryst Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Biocryst Pharmaceuticals | (BCRX) share price targets
Complete technical analysis of Biocryst Pharmaceuticals (BCRX) by charts plus indicators, forecast predictions and share price targets for Biocryst Pharmaceuticals (BCRX)
Biocryst Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-26 View latest technical analysis
10 day averaged volume of Biocryst Pharmaceuticals is 3862090
Date | Daily Closing Price | Open | High | Low | Volume |
26 Wed Jun 2024 | 6.18 | 6.01 | 6.24 | 6.00 | 0.609 times |
25 Tue Jun 2024 | 6.08 | 6.26 | 6.28 | 6.06 | 0.462 times |
24 Mon Jun 2024 | 6.27 | 6.46 | 6.58 | 6.24 | 0.581 times |
21 Fri Jun 2024 | 6.42 | 6.18 | 6.55 | 6.18 | 4.007 times |
20 Thu Jun 2024 | 6.15 | 5.98 | 6.20 | 5.92 | 0.647 times |
18 Tue Jun 2024 | 6.00 | 6.22 | 6.23 | 6.00 | 0.659 times |
18 Tue Jun 2024 | 6.00 | 6.22 | 6.23 | 6.00 | 0.659 times |
17 Mon Jun 2024 | 6.24 | 6.12 | 6.25 | 5.99 | 0.911 times |
14 Fri Jun 2024 | 6.17 | 6.13 | 6.20 | 6.00 | 0.762 times |
13 Thu Jun 2024 | 6.23 | 6.30 | 6.40 | 6.11 | 0.677 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 6.1 as stoploss in an intra day buy trade for a target of 6.36. However, stock will show a bearish move below 6.1.
Share price targets for Biocryst Pharmaceuticals (BCRX)
Target Type | Value |
Downside Target | 4.03 |
Downside Target | 4.15 |
Downside Target | 4.82 |
Downside Target | 4.93 |
Downside Target | 5.16 |
Downside Target | 5.89 |
Downside Target | 6.13 |
Upside Target | 6.55 |
Upside Target | 6.58 |
Upside Target | 6.76 |
Upside Target | 6.89 |
Upside Target | 6.99 |
Intraday share price targets for Biocryst Pharmaceuticals (BCRX)
Target Type | Value |
Downside Intraday Target | 5.93 |
Downside Intraday Target | 5.67 |
Upside Intraday Target | 6.51 |
Upside Intraday Target | 6.83 |
Upside Intraday Target | 6.25 |
Weekly technical analysis of Biocryst Pharmaceuticals (BCRX)
Date | Weekly Closing Price | Open | High | Low | Volume |
26 Wed Jun 2024 | 6.18 | 6.46 | 6.58 | 6.00 | 0.311 times |
21 Fri Jun 2024 | 6.42 | 6.22 | 6.55 | 5.92 | 3.383 times |
18 Tue Jun 2024 | 6.00 | 6.12 | 6.25 | 5.99 | 0.437 times |
14 Fri Jun 2024 | 6.17 | 6.25 | 6.76 | 6.00 | 0.856 times |
07 Fri Jun 2024 | 6.31 | 6.66 | 6.99 | 6.13 | 1.101 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biocryst Pharmaceuticals (BCRX)
Date | Monthly Closing Price | Open | High | Low | Volume |
26 Wed Jun 2024 | 6.18 | 6.66 | 6.99 | 5.92 | 0.687 times |
31 Fri May 2024 | 6.46 | 4.18 | 6.89 | 4.15 | 1.324 times |
30 Tue Apr 2024 | 4.13 | 5.04 | 5.16 | 4.03 | 1.017 times |
28 Thu Mar 2024 | 5.08 | 5.67 | 5.89 | 4.82 | 1.106 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biocryst Pharmaceuticals (BCRX)
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biocryst Pharmaceuticals in short term but the sell signal is initial and weak.
Biocryst Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Biocryst Pharmaceuticals in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biocryst Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.26 and Biocryst Pharmaceuticals (BCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals (BCRX) stock. Volume based technical analysis of Biocryst Pharmaceuticals (BCRX) stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biocryst Pharmaceuticals in short term but the sell signal is initial and weak.
Biocryst Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Biocryst Pharmaceuticals in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biocryst Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.26 and Biocryst Pharmaceuticals (BCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals (BCRX) stock. Volume based technical analysis of Biocryst Pharmaceuticals (BCRX) stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.